Alcohol Dependence
Conditions
Keywords
Contingency Management, Alcohol Dependence
Brief summary
The purpose of this study is to evaluate the efficacy of prize contingency management (CM) in reducing in-patient detoxification services for chronic recidivist alcohol-dependent patients.
Detailed description
This study evaluates the efficacy of prize contingency management (CM) in reducing in-patient detoxification services for chronic recidivist alcohol-dependent patients. 116 alcohol-dependent patients who have received 4 or more alcohol detoxifications in a calendar year will be randomly assigned to one of two 6-month treatment conditions: standard case management treatment, or standard case management treatment plus CM. In the CM condition, patients earn the chance to win prizes by submitting negative breath samples and by complying with steps toward treatment goals, such as attending outpatient substance abuse treatment services, attending appointments with low income housing programs, or complying with outpatient psychiatric treatment. Treatment services received, alcohol and drug use, psychosocial functioning, and HIV risk behaviors will be measured pre-treatment and at months 1, 3, and 6 (post-treatment), and at follow-ups scheduled for 9, 12, and 18 months after intake.
Interventions
prize contingency management (CM) -- 6-month treatment plus standard case management treatment and follow-ups at 9, 12, and 18 months after intake
6-month treatment standard case management treatment, and follow-ups scheduled at 9, 12, and 18 months after intake.
Sponsors
Study design
Eligibility
Inclusion criteria
* age 18 years or older * Four or more inpatient alcohol detoxifications in the previous 12 months * current diagnosis of DSM-IV alcohol dependence
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| number of detoxifications | 9, 12, and 18 months after intake |
| objective alcohol use | 9, 12, and 18 months after intake |
| self-reported alcohol use | 9, 12, and 18 months after intake |
Secondary
| Measure | Time frame |
|---|---|
| BSI scores | 9, 12, and 18 months after intake |
| objective drug use | 9, 12, and 18 months after intake |
| ASI composite scores | 9, 12, and 18 months after intake |
| HRBS scores | 9, 12, and 18 months after intake |
Countries
United States